Pacira Pharmaceuticals Inc (PCRX): Kronenfeld’s Yearly AcquisitionBy Jodor JalitNovember 5, 2014 Mark A. Kronenfeld, Director at Pacira Pharmaceuticals Inc (NASDAQ:PCRX) disclosed today the acquisition of 850 shares of common stock in…